secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2023-11-07T23:59:59+00:00
Accession:  0000950170-23-060250
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical Q3 revenue $30.4M (+9% YoY); net loss $46.2M; reiterates FY23 guidance ~$130M
--------------------------------------------------------------------------------

- Revenue $30.4M, +9% YoY; product rev $23.5M (+8.2%), service rev $6.8M (+13.4%).
- GAAP gross margin 23.6% (vs 15.6% YoY); non-GAAP 25.6% (vs 16.4% YoY). Service margin dropped to 6.8% from 37%.
- Net loss $46.2M ($0.93/share); non-GAAP net loss $35.3M ($0.71/share).
- Cash $197M as of Sept 30; operating expenses $52.6M.
- Reiterated 2023 revenue guidance ~$130M, gross margin low-20% for year, mid-20% in Q4.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000095017023060250/0000950170-23-060250-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000095017023060250/om-20231107.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-060250

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer